Moolec Science Stock Price, News & Analysis

Moolec Science SA (NASDAQ:MLEC) has entered a Share Purchase Agreement with Nomura Securities International, allowing the company to sell up to $50 million in ordinary shares over 36 months. This financing facility enhances Moolec's financial flexibility for its Molecular Farming initiatives. The proceeds will support general corporate purposes, helping advance the company's mission to produce animal proteins in plants. Moolec's innovative technology has a decade-long development history and focuses on sustainable food production, utilizing crops like safflower, soybean, and pea. Moolec currently holds 23 patents to strengthen its position in the alternative protein market.

For further details, refer to the Current Report on Form 6-K filed with the SEC.

Moolec Science SA (NASDAQ:MLEC) recently announced its acquisition of ValoraSoy, a strategic move aimed at enhancing its plant-based food ingredient capabilities for functional soy proteins. This $6 million transaction comprises approximately $2.5 million in cash and the remainder in shares, contingent upon performance metrics over three years. The acquisition equips Moolec with state-of-the-art processing facilities and a robust sales team, expanding its reach across more than 14 countries. The integration is expected to accelerate sales and generate estimated revenues of $6 million in the 2023/2024 period. Moolec aims to leverage its Molecular Farming platform to lower protein costs and improve product quality, addressing global food security challenges.

Moolec Science SA (NASDAQ:MLEC) announced that the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) concluded that its GLA safflower plants pose no greater pest risk than non-GE safflower plants. This regulatory clearance enhances Moolec's operational efficiency, as permits for interstate movement and growing these plants are no longer required. CEO Gastón Paladini highlighted this milestone as a validation of their regulatory strategy, while Chief of Technology Martin Salinas expressed optimism about upcoming regulatory reviews. Moolec aims to improve food products' nutritional profiles and sustainability through its Molecular Farming technology.

Moolec Science SA (NASDAQ: MLEC) announced it will ring the Nasdaq closing bell on January 17, 2023, celebrating its trading debut on January 3, 2023. This milestone reflects the company's pioneering role in the Molecular Farming movement, aimed at producing animal proteins in plants for enhanced food security and sustainability. CEO Gastón Paladini emphasized that the listing increases visibility and access to global capital markets, fostering growth and innovation in alternative proteins. Moolec Science develops technology with over a decade of research, boasting a diversified patent portfolio for its innovations in food.

Moolec Science Ltd. and LightJump Acquisition Corporation have successfully completed their business combination on December 30, 2022. Moolec Science will now trade on Nasdaq under the tickers MLEC for its common shares and MLECW for its warrants, starting January 3, 2023. Moolec Science specializes in producing animal proteins in plants through Molecular Farming, positioning itself as a leader in the alternative protein sector. The company aims to innovate food systems while enhancing taste, nutrition, and sustainability.